When the body detects injury, infection, or harmful substances, the immune system quickly responds by creating inflammation. This process helps protect us by sending immune cells to the affected area to destroy invaders and repair damaged tissue.
A key part of this response involves small signaling proteins called chemokines. These proteins act like emergency beacons, guiding immune cells to exactly where they are needed. Without chemokines, the body would struggle to fight infections effectively.
However, the immune system can sometimes become overactive. Instead of protecting the body, it may attack healthy tissues, leading to autoimmune and inflammatory diseases such as rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease.
In these conditions, chemokines continue to call immune cells into action even when there is no real threat, causing long-term inflammation and damage. Scientists have been searching for ways to control this process safely so that harmful inflammation can be reduced without weakening the body’s ability to fight real infections.
A new study from researchers at the Monash University Biomedicine Discovery Institute in Australia has revealed a surprising clue from nature. The team studied ticks, tiny parasites that feed on blood.
Despite attaching to humans or animals for hours or even days, ticks often go unnoticed because they can suppress the host’s immune response. They achieve this by releasing special proteins in their saliva that block chemokines, preventing the immune system from detecting the bite.
These proteins are called evasins because they help the tick evade the body’s defenses. Scientists realized that if these molecules can block chemokines during a tick bite, they might also be useful for treating diseases caused by excessive inflammation.
Until now, known evasins could only block one specific group of chemokines at a time, which limited their potential as treatments.
In the new research, published in the journal Structure, the scientists discovered a naturally occurring evasin that can block two major groups of chemokines at once. This makes it much more powerful than previously identified versions.
The study was led by Professor Martin Stone and Dr. Ram Bhusal, along with an international team of researchers. They found that this broad-acting evasin could interfere with the signals that drive harmful immune responses, offering a new strategy for treating autoimmune diseases.
The finding challenges earlier assumptions about how ticks suppress immunity. Scientists had believed that ticks needed to produce many different evasins, each targeting a specific chemokine type.
Instead, this study shows that a single protein may be able to block multiple pathways. This simplifies the concept of how immune suppression occurs and opens the door to designing medicines based on this natural mechanism.
Researchers believe that therapies inspired by this discovery could slow or stop the progression of diseases in which inflammation damages tissues over time. Current treatments often reduce symptoms but may not fully prevent long-term harm. A therapy that directly blocks the signals causing inflammation could offer a more effective solution.
In reviewing the study, the discovery is significant because it reveals a new biological tool that could be adapted for medical use. The fact that the protein occurs naturally suggests it may work efficiently in living systems.
However, the research is still at an early stage, and further studies are needed to confirm safety and effectiveness in humans. Scientists will need to determine whether such treatments could suppress harmful inflammation without increasing the risk of infection.
Overall, the study highlights how observing nature can lead to breakthroughs in medicine. A parasite that evolved to avoid detection may now provide clues for treating serious human diseases.
As research continues, this tick-derived protein could become the basis for new therapies that improve the lives of people living with autoimmune and inflammatory conditions.
If you care about cancer, please read studies about how to fight cancer with these anti-cancer superfoods ,and a berry that can prevent cancer, diabetes and obesity.
For more health information, please see recent studies about how to harness the power of anti-cancer foods and supplements, and cancer-fighting foods and recipes.
The study is published in Structure.
Copyright © 2026 Knowridge Science Report. All rights reserved.
